Canopy Immuno-Therapeutics Overview
Canopy is a pre-clinical stage biotech developing a new class of biologics that will allow the elimination of antigen-specific immunity, providing non-immunosuppressive, potentially curing treatments to many dozens of autoimmune, allergic, and other antibody-mediated conditions using its proprietary Reverse-Immunization platform.
Cumulative Funding Raised Over Time ($)
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | A |
| Rounds | 2 |
| Investors | 1 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | canopy-biotech.com |
Locations
Haifa, Israel
Photos & Videos
1 item(s)
Canopy Immuno-Therapeutics Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesBiotechnologyCore Technology
Platforms & InterfacesSoftwareArtificial IntelligenceTags (11)
biotechnologyinflammatory-diseasesallergytreatmentsartificial-intelligencesoftware-platformlife-sciencesimmunologyimmuno-theraphydrug-developmentimmunotherapyGeographic Markets
GlobalCanopy Immuno-Therapeutics Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Canopy Immuno-Therapeutics Lifecycle
Cumulative Funding Raised Over Time
All Events
Canopy Immuno-Therapeutics News
1 articleCanopy Immuno-Therapeutics Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
Canopy Immuno-Therapeutics Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 98/100 |
| Missing | markets |
| BI Verification | Yotam Maman |
| Registrar ID | 516091204 |
| Crunchbase | canopy-immuno-therapeutics |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-03-21T00:00:00.000Z |
| Created | 2021-10-07T00:00:00.000Z |
| Claimed | Yes |